The Rx Daily Dose

In this episode we go over FDA approval of Zeposia for multiple sclerosis, and a statement the FDA came out with regarding the use of ibuprofen with COVID19 infection. And we’ll be giving our usual update on the novel coronavirus and flu season to date. Don't forget to like, share, and subscribe! Enjoy!

In this episode we give an overview of a new safety warning by the FDA on SGLT2 use while having a surgery, and approval of Epclusa in pediatric patients age 6 years and older. We'll also give an overview of the FDA guidance on compounding hand sanitizer. And we’ll be giving our usual update on the novel coronavirus and flu season to date. Don't forget to like, share, and subscribe! Enjoy!

In this episode we give an overview of new product approvals by the FDA including Isturisa for Cushing’s disease and added indications for Ofev for chronic fibrosing interstitial lung disease, and the combination of Opdivo and Vervoy for hepatocullular carcinoma. And we’ll be giving our usual update on the novel coronavirus and flu season to date. Don't forget to like, share, and subscribe! Enjoy!

In this episode we'll be giving overview of new product approvals by the FDA including Sarclisa for multiple myeloma and Durysta, as well as a new boxed warning put on the drug Singulair. We continue to receive updates and new information on coronavirus, well provide updates on seasonal flu numbers in the US as well as an update on the state of COVID19. Don't forget to like, share and subscribe! Enjoy!

In this episode - a busy week for the FDA, we talk about new approvals including: Nexletol, Nexlizet, Anjeso, Vyepti, Nurtec ODT, & Barhemsys. We also talk about an added indication for Nerlynx and give our regular update on flu season and the coronavirus. Don't forget to download, share, and subscribe! Enjoy!

In episode 22, we discuss approval of Twirla and Procysbi granules by the FDA. We also talk about FDA moving 3 products from prescription to over-the-counter (OTC). We also give updates from the CDC on influenza season and on the coronavirus outbreak from China. Don't forget to download, share, and subscribe! Enjoy!

In episode 21, we discuss approval of Pemfexy and Pizensy by the FDA. We also talk about the withdrawal of Belviq from the US market. We also give updates from the CDC on influenza season and on the coronavirus outbreak from China. Don't forget to download, share, and subscribe! Enjoy!

In episode 20 we discuss approval of Palforzia for peanut allergy, Monoferric for iron deficiency anemia, and approval of Audenz for H5N1 pandemic flu. We also talk about breakthrough therapy designation for apabetalone, and updates from the CDC on nCoV - coronavirus, and a status check on influenza season so far. Don't forget to like share and subscribe! Enjoy!

In episode 19 we discuss Dificid being used in pediatric patients 6 months and older and a new combination product, Trijardy, for the treatment of type 2 diabetes. We also give recent updates on the novel coronavirus from Wuhan, China and we talk about an article that came out from the NY Times about the stresses & pressures of working retail. Don't forget to share and subscribe! Enjoy!

In this episode we talk about updates in the diabetes landscape, most notable with Ozempic and some SGLT2 products. We also discuss approval of Valtoco for seizure rescue treatment, Tepezza for thyroid eye disease, and Tavzerik for epithelioid sarcoma. We also give updates on the FDA drug watchlist, and an overview of whats going on with the emerging Coronavirus out of China. Don't forget to share & subscribe to keep the momentum going! Thanks for listening!